Targeting BCR-ABL and JAK2 in Ph+ ALL

被引:3
|
作者
Hantschel, Oliver [1 ]
机构
[1] Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland
关键词
INHIBITION; JAK2-STAT5; IMATINIB; CELLS;
D O I
10.1182/blood-2014-12-617548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1362 / 1363
页数:3
相关论文
共 50 条
  • [1] Evidence that Bcr-Abl activates Jak2 by direct tyrosine phosphorylation, and Jak2 activation by Bcr-Abl is involved in blocking apoptosis.
    Xie, SH
    Liu, JX
    Sun, T
    Arlinghaus, RB
    BLOOD, 2000, 96 (11) : 92A - 92A
  • [2] Combined Targeting of BCR-ABL and JAK2 with ABL and JAK2 Inhibitors Is Effective Against CML Patients' Leukemic Stem/Progenitor Cells
    DeGeer, Donna
    Gallipoli, Paolo
    Chen, Min
    Sloma, Ivan
    Jorgensen, Heather
    Forrest, Donna
    Lambie, Karen
    Nakamoto, Helen
    Saw, Kyi Min
    Chan, Matthew
    Newmarch, Kathleen
    Zhou, Leon
    Turhan, Ali G.
    Arlinghaus, Ralph B.
    Eaves, Allen C.
    Eaves, Connie J.
    Holyoake, Tessa L.
    Jing, Xiaoyan
    BLOOD, 2010, 116 (21) : 1393 - 1394
  • [3] Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation
    Xie, SH
    Wang, Y
    Liu, JX
    Sun, T
    Wilson, MB
    Smithgall, TE
    Arlinghaus, RB
    ONCOGENE, 2001, 20 (43) : 6188 - 6195
  • [4] Targeting BCL-2 and BCR-Abl Activity in Ph plus ALL
    Leonard, Jessica T.
    Traer, Elie
    Hayes-Lattin, Brandon
    Tyner, Jeffrey
    Druker, Brian
    Chang, Bill H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S190 - S190
  • [5] Clonal Competition Between JAK2 and BCR-ABL in Myeloproliferative Neoplasm
    Salk, Gabriel
    Mangala, Yashvin Onkarappa
    Onukogu, Ifeanyichukwu David
    Meleveedu, Kapil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S384 - S384
  • [6] Off-Target Effects of BCR-ABL and JAK2 Inhibitors
    Green, Myke R.
    Newton, Michael D.
    Fancher, Karen M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 76 - 84
  • [7] Jak2 is involved in c-Myc induction by Bcr-Abl
    Shanhai Xie
    Hui Lin
    Tong Sun
    Ralph B Arlinghaus
    Oncogene, 2002, 21 : 7137 - 7146
  • [8] Jak2 is involved in c-Myc induction by Bcr-Abl
    Xie, SH
    Lin, H
    Sun, T
    Arlinghaus, RB
    ONCOGENE, 2002, 21 (47) : 7137 - 7146
  • [9] Jak2 is involved in c-Myc induction by Bcr-Abl
    Xie, SH
    Lin, H
    Sun, T
    Arlinghaus, RB
    FASEB JOURNAL, 2002, 16 (05): : A1199 - A1199
  • [10] ACCELERATION OF BCR-ABL plus LEUKEMIA INDUCED BY DELETION OF JAK2
    Grundschober, E.
    Hoelbl-Kovacic, A.
    Bhagwat, N.
    Levine, R.
    Sexl, V.
    HAEMATOLOGICA, 2014, 99 : 794 - 794